| Durelle Tower Scott, MD | |
|
610 Wyoming Ave, Kingston, PA 18704-3702 | |
| (570) 288-5441 | |
| (570) 288-9613 |
| Full Name | Durelle Tower Scott |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 610 Wyoming Ave, Kingston, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245243591 | NPI | - | NPPES |
| 000732595 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD030648L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Durelle Tower Scott, MD 610 Wyoming Ave, Kingston, PA 18704-3702 Ph: (570) 288-5441 | Durelle Tower Scott, MD 610 Wyoming Ave, Kingston, PA 18704-3702 Ph: (570) 288-5441 |
News Archive
Golden Meditech Company Limited, a leading hi-tech medical device and healthcare service corporation in China, today announced that its hospital subsidiary - Golden Meditech Hospital Group (GMHG) has entered into an agreement to issue senior 5% redeemable convertible notes due in 2014 with an aggregate principal amount of US$28 million (equivalent to approximately HK$217 million).
The world's largest gathering of kidney health professionals-Kidney Week 2014-will take place November 11-16 in Philadelphia, PA. The annual meeting of the American Society of Nephrology, Kidney Week will showcase new scientific and clinical advances in nephrology from across the globe.
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.
elsPharma Major Lupin Limited announced that its U.S. subsidiary, Lupin Pharmaceuticals, Inc. has received tentative approval for its Armodafinil Tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths as well as another tentative approval for its Doxycycline Capsules, 40 mg (30 mg Immediate-release and 10 mg Delayed-release) from the United States Food and Drugs Administration.
"Scientists from the University of Melbourne, Australia, the United States and Malawi studying infections with malaria and HIV, have found a strong link between the two diseases, which affect millions of people around the world and are major scourges in sub-Saharan Africa.
› Verified 2 days ago
Dr. Farook K Shroff, M.D., F.A.C.C. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 517 Pierce St, Kingston, PA 18704 Phone: 570-371-3536 Fax: 570-371-3539 | |
Dr. Bruce H Saidman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 382 Pierce St, Kingston, PA 18704 Phone: 570-288-7231 | |
Jeffrey Dandrea, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 517 Pierce St, Kingston, PA 18704 Phone: 570-371-3536 Fax: 570-371-3539 | |
Frederick Myers, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 540 Gibson Ave, Kingston, PA 18704 Phone: 570-283-9357 | |
Rachel Dela Cruz Canseco-berbano, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 445 Wyoming Avenue, Kingston, PA 18704 Phone: 570-718-0505 Fax: 570-718-0522 | |
James M Jiunta, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 417 Market St, Kingston, PA 18704 Phone: 570-287-4200 | |
John G. Citti, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 Wyoming Ave, Kingston, PA 18704 Phone: 570-288-5441 Fax: 570-288-9613 |